Q1- The Highlights

The first quarter of 2016 hosted plenty of activity from the pharma and cold chain industries. This was seen in the form of patent challenges, landmark agreements, extreme market reactions as well as a nationwide medicine ban for hundreds of products. Read on for this quarter’s highlights from Pharma IQ. Regulator UpdateIndia’s Health Ministry Bans Over 330 Combination DrugsThe notification which was published in early March stated the near to immediate prohibition of manufacture or sale of...
To continue reading this story get free access